543 related articles for article (PubMed ID: 23933153)
1. Familial pheochromocytomas and paragangliomas.
King KS; Pacak K
Mol Cell Endocrinol; 2014 Apr; 386(1-2):92-100. PubMed ID: 23933153
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
3. [Genetics of paragangliomas and pheochromocytomas].
Favier J; Gimenez-Roqueplo AP
Med Sci (Paris); 2012; 28(6-7):625-32. PubMed ID: 22805139
[TBL] [Abstract][Full Text] [Related]
4. Genetics of pheochromocytomas and paragangliomas.
Opocher G; Schiavi F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
[TBL] [Abstract][Full Text] [Related]
5. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
[TBL] [Abstract][Full Text] [Related]
6. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
[TBL] [Abstract][Full Text] [Related]
7. A Guide to Pheochromocytomas and Paragangliomas.
Guilmette J; Sadow PM
Surg Pathol Clin; 2019 Dec; 12(4):951-965. PubMed ID: 31672301
[TBL] [Abstract][Full Text] [Related]
8. The genetic basis of pheochromocytoma and paraganglioma: implications for management.
Shuch B; Ricketts CJ; Metwalli AR; Pacak K; Linehan WM
Urology; 2014 Jun; 83(6):1225-32. PubMed ID: 24642075
[TBL] [Abstract][Full Text] [Related]
9. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
10. Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population.
Choi H; Kim KJ; Hong N; Shin S; Choi JR; Kang SW; Lee ST; Rhee Y
Endocrinol Metab (Seoul); 2020 Dec; 35(4):858-872. PubMed ID: 33397040
[TBL] [Abstract][Full Text] [Related]
11. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
12. [Pathologist contribution in the diagnosis of hereditary predisposition to paranganglioma and pheochromocytoma].
Broudin C; Favier J; Verkarre V; Méatchi T
Ann Pathol; 2020 Apr; 40(2):134-141. PubMed ID: 32146049
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study.
Favier J; Meatchi T; Robidel E; Badoual C; Sibony M; Nguyen AT; Gimenez-Roqueplo AP; Burnichon N
Mod Pathol; 2020 Jan; 33(1):57-64. PubMed ID: 31383958
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
[TBL] [Abstract][Full Text] [Related]
15. Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions.
Pellegata NS; Quintanilla-Martinez L; Keller G; Liyanarachchi S; Höfler H; Atkinson MJ; Fend F
Virchows Arch; 2007 Jul; 451(1):37-46. PubMed ID: 17554557
[TBL] [Abstract][Full Text] [Related]
16. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.
Rich T; Jackson M; Roman-Gonzalez A; Shah K; Cote GJ; Jimenez C
Fam Cancer; 2015 Dec; 14(4):615-9. PubMed ID: 26162468
[TBL] [Abstract][Full Text] [Related]
17. What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?
Papathomas TG; Suurd DPD; Pacak K; Tischler AS; Vriens MR; Lam AK; de Krijger RR
Endocr Pathol; 2021 Mar; 32(1):134-153. PubMed ID: 33433885
[TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
[TBL] [Abstract][Full Text] [Related]
19. Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma.
Jiang J; Zhang J; Pang Y; Bechmann N; Li M; Monteagudo M; Calsina B; Gimenez-Roqueplo AP; Nölting S; Beuschlein F; Fassnacht M; Deutschbein T; Timmers HJLM; Åkerström T; Crona J; Quinkler M; Fliedner SMJ; Liu Y; Guo J; Li X; Guo W; Hou Y; Wang C; Zhang L; Xiao Q; Liu L; Gao X; Burnichon N; Robledo M; Eisenhofer G
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32750708
[TBL] [Abstract][Full Text] [Related]
20. Novel hereditary forms of pheochromocytomas and paragangliomas.
Dahia PL
Front Horm Res; 2013; 41():79-91. PubMed ID: 23652672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]